Seoul St. Mary's Hospital Presents Evidence for Personalized Treatment Strategy
Significant Chemotherapy Benefits Seen in High-Risk Stage III Patients Aged 75 and Older

A new study has found that personalized treatment based on cancer stage and risk, rather than age, improves survival rates in colon cancer patients aged 75 and older.


From the left, Yoon Seok Lee and Jeong Hun Bae, professors of the Department of Colon and Rectal Surgery at Seoul St. Mary's Hospital Cancer Center. Seoul St. Mary's Hospital

From the left, Yoon Seok Lee and Jeong Hun Bae, professors of the Department of Colon and Rectal Surgery at Seoul St. Mary's Hospital Cancer Center. Seoul St. Mary's Hospital

View original image

On May 4, Seoul St. Mary's Hospital announced that the research team led by Professor Yoon Seok Lee of the Colorectal Surgery Department had analyzed patient data from five hospitals under the Catholic Medical Center and confirmed that adjuvant chemotherapy is particularly effective in certain high-risk elderly colon cancer patients.


The study targeted 394 patients aged 75 or older out of 1,585 who underwent surgery for colon cancer. Among these, the proportion who received chemotherapy was 46.7%, about half the rate compared to patients under 75 (87.9%).


The analysis revealed that the benefits of chemotherapy were most pronounced in high-risk stage III patients. In this group, those who received chemotherapy had a 5-year overall survival rate of 78.6%, which was 29.5 percentage points higher than those who did not receive chemotherapy (49.1%). The 5-year disease-free survival rate also improved from 48.2% to 69.3%. In contrast, the effects of chemotherapy were relatively limited in high-risk stage II and low-risk stage III patients, highlighting the need for a selective treatment strategy based on individual patient risk.


The research team assessed that these results could serve as a basis for future treatment strategies for elderly colon cancer patients in a super-aged society. The related study received the Best Poster Award at the American Society of Colon and Rectal Surgeons (ASCRS).



Professor Bae, who led the study, stated, "The core of all medical care is to thoroughly examine the practical benefits patients can gain and maximize treatment effectiveness. If chemotherapy is administered based on a thorough pre-treatment evaluation by medical professionals, even high-risk stage III elderly patients can expect significant improvements in survival and quality of life."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing